fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Sleep apnea may lead to increased joint pain in postmenopausal women

Written by | 5 Mar 2022

The menopause transition is associated with several health issues. The incidence of both sleep apnea and joint pain, for example, are higher in postmenopausal women. A new study… read more.

Potential target for treating osteoporosis

Written by | 15 Feb 2022

Channels on the surface of bone cells called osteocytes help build stronger bones in response to mechanical stress, shows a study published today in eLife. This discovery may help… read more.

Epstein-Barr virus may be leading cause of multiple sclerosis

Written by | 4 Feb 2022

Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure, is likely caused by infection with the Epstein-Barr… read more.

How obesity damages the skeletal muscle metabolism

Written by | 5 Dec 2021

A decline in metabolism and endurance of skeletal muscle is commonly observed in obese patients, but the underlying mechanism is not well-understood. A research team led by Dr… read more.

Patient-specific plates may help heal collarbone fractures

Written by | 29 Nov 2021

Fractures of the clavicle, or collarbone, are common. Unfortunately, current fixation plates that are used to surgically stabilize these fractures are suboptimal, leading to reoperation rates of up… read more.

Same-day discharge for hip and knee replacement surgery is safe and feasible in high-risk patients, study suggests

Written by | 4 Nov 2021

Same-day discharge after total knee arthroplasty (TKA) or total hip arthroplasty (THA) is safe in some patients classified as “high risk” – with no increase in complications or other… read more.

Phase III ATOM trial of Tymlos shows positive results in osteoporosis – Radius Health

Written by | 30 Oct 2021

Radius Health announced positive topline results from the ATOM study evaluating Tymlos (abaloparatide) 80mcg subcutaneous (SC) for use in males with osteoporosis. The ATOM study met its primary… read more.

Stem cell population identified as key for bone regeneration

Written by | 26 Oct 2021

Mesenchymal stem cells (MSCs) are thought to have great potential in the field of regenerative medicine, which has the aim of restoring damaged tissues. However, not much was… read more.

New online platform facilitates recognition for Fracture Liaison Services

Written by | 21 Oct 2021

The International Osteoporosis Foundation’s (IOF) Capture the Fracture® program has launched a new, enhanced online platform to enable coordinated post-fracture care services (including ‘Fracture Liaison Services’, or FLS) to… read more.

EASD 2021: Osteoporosis drug appears to lower diabetes risk

Written by | 5 Oct 2021

Treatment with alendronate, an osteoporosis drug, appears to reduce the risk of developing type 2 diabetes, researchers reported on Sept. 26, 2021 at the annual meeting of the… read more.

Drug cocktail reduces aging-associated disc degeneration

Written by | 12 Sep 2021

Chronic back pain affects upwards of 15 million adults in the US, racking up billions in healthcare costs and lost work days. Degeneration of the discs that cushion… read more.

Cognitive decline linked to bone loss and fracture risk

Written by | 5 Aug 2021

New research carried out under the auspices of the Canadian Multicentre Osteoporosis Study (CaMos) has found that cognitive decline is linked with accelerated bone loss and an increased… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.